- Associated Press•40 minutes ago
The latest on developments in U.S. financial markets: 11:45 a.m. Stocks are rising in midday trading after the government said the U.S. economy broke out of a recent slump and grew at a solid clip in the ...
- Barrons.com•43 minutes ago
Amgen (AMGN) has tumbled more than 10% this morning despite beating earnings forecasts. Leerink's Geoffrey Porges and Bradley Canino explain what went wrong: Amgen Reported Q2 Results Yesterday With a Modest Revenue Beat and EPS Upside on Margins. The real story however, is likely to be the outlook for Enbrel and the impact of the company’s new contracts, and their pricing effect.
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||143.84 x 100|
|Ask||143.90 x 300|
|Day's Range||142.80 - 151.76|
|52wk Range||139.02 - 176.85|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||14.69|
|Avg Vol (3m)||2,785,132|
|Dividend & Yield||4.00 (2.52%)|